Suchergebnisse - "Dellepiane, Chiara"

PubPharm (38)

1

Circulating Osteopontin Predicts Clinical and Radiological Response in First-Line Treatment of Advanced Non-Small Cell Lung Cancer

enthalten in: Lung | 2024

von Ramoni, D. | Coco, S. | Rossi, G. | +14

2

Extracellular vesicles miR-574-5p and miR-181a-5p as prognostic markers in NSCLC patients treated with Nivolumab

enthalten in: ResearchSquare.com | 2024

von Genova, C. | Marconi, S. | Chiorino, G. | +25

3

Circulating Osteopontin Predicts Clinical and Radiological Response in First-Line Treatment of Advanced Non-Small Cell Lung Cancer

enthalten in: Lung | 2024

von Ramoni, D. | Coco, S. | Rossi, G. | +14

4

Nivolumab in pretreated pleural mesothelioma : Results from an observational real-world study of patients treated within the AIFA 5% Fund

enthalten in: Tumori | 2024

von Cerbone, L. | Delfanti, S. | Crivellari, S. | +18

5

Molecular and Genetic Advances in Small Cell Lung Cancer Landscape : From Homogeneity to Diversity

enthalten in: International journal of molecular sciences | 2023

von Zullo, L. | Dall'Olio, F. | Rossi, G. | +6

6

Diagnosis of lung cancer following emergency admission : Examining care pathways, clinical outcomes, and advanced NSCLC treatment in an Italian cancer Center

enthalten in: Heliyon | 2023

von Vallome, G. | Cafaro, I. | Bottini, A. | +26

7

Prognostic Role of Soluble and Extracellular Vesicle-Associated PD-L1, B7-H3 and B7-H4 in Non-Small Cell Lung Cancer Patients Treated with Immune Checkpoint Inhibitors

enthalten in: Cells | 2023

von Genova, C. | Tasso, R. | Rosa, A. | +22

8

Immune Checkpoint Blockade : A Strategy to Unleash the Potential of Natural Killer Cells in the Anti-Cancer Therapy

enthalten in: Cancers | 2022

von Grottoli, M. | Carrega, P. | Zullo, L. | +16

9

Immunotherapy-chemotherapy combinations for non-small cell lung cancer : current trends and future perspectives

enthalten in: Expert opinion on biological therapy | 2022

von Cella, E. | Zullo, L. | Marconi, S. | +13

10

A Circulating Risk Score, Based on Combined Expression of Exo-miR-130a-3p and Fibrinopeptide A, as Predictive Biomarker of Relapse in Resectable Non-Small Cell Lung Cancer Patients

enthalten in: Cancers | 2022

von Marconi, S. | Croce, M. | Chiorino, G. | +23